New drug SUL-238 put to the test in healthy volunteers
NCT ID NCT06277492
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested the safety of a new experimental drug, SUL-238, in 83 healthy adults aged 40 and older. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moved through the body. The goal was not to treat any disease, but to gather important safety information before testing in patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Erciyes University IKUM Center
Kayseri, 38030, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- Sound waves as medicine: ultrasound may tame inflammation without drugs
- Broader pneumonia shield: new vaccine tested in children
- Scientists probe nerve signals to give prosthetics a sense of touch
- Healthy men test new drug to see if different factories make it the same
- New eye imaging study aims to map retinal disease progression